| WikiPathways: a multifaceted pathway database bridging metabolomics to other omics research DN Slenter, M Kutmon, K Hanspers, A Riutta, J Windsor, N Nunes, ... Nucleic acids research 46 (D1), D661-D667, 2018 | 418 | 2018 |
| Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen MP Menden, D Wang, MJ Mason, B Szalai, KC Bulusu, Y Guan, T Yu, ... Nature communications 10 (1), 1-17, 2019 | 92 | 2019 |
| Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification MA La Merrill, LN Vandenberg, MT Smith, W Goodson, P Browne, ... Nature Reviews Endocrinology, 2019 | 90 | 2019 |
| Aflatoxin B1 induces persistent epigenomic effects in primary human hepatocytes associated with hepatocellular carcinoma L Rieswijk, SMH Claessen, O Bekers, M van Herwijnen, DHJ Theunissen, ... Toxicology 350, 31-39, 2016 | 49 | 2016 |
| A data fusion pipeline for generating and enriching adverse outcome pathway descriptions P Nymark, L Rieswijk, F Ehrhart, N Jeliazkova, G Tsiliki, H Sarimveis, ... Toxicological Sciences 162 (1), 264-275, 2018 | 30 | 2018 |
| Proposed key characteristics of female reproductive toxicants as an approach for organizing and evaluating mechanistic data in hazard assessment U Luderer, B Eskenazi, R Hauser, KS Korach, CM McHale, F Moran, ... Environmental health perspectives 127 (7), 075001, 2019 | 19 | 2019 |
| Evaluating microRNA profiles reveals discriminative responses following genotoxic or non-genotoxic carcinogen exposure in primary mouse hepatocytes L Rieswijk, KJJ Brauers, MLJ Coonen, SGJ Van Breda, DGJ Jennen, ... Mutagenesis 30 (6), 771-784, 2015 | 17 | 2015 |
| Key characteristics approach to carcinogenic hazard identification KZ Guyton, L Rieswijk, A Wang, WA Chiu, MT Smith Chemical research in toxicology 31 (12), 1290-1292, 2018 | 14 | 2018 |
| Characterisation of cisplatin-induced transcriptomics responses in primary mouse hepatocytes, HepG2 cells and mouse embryonic stem cells shows conservation of regulating … L Rieswijk, D Lizarraga, KJJ Brauers, JCS Kleinjans, JHM van Delft Mutagenesis 29 (1), 17-26, 2014 | 14 | 2014 |
| The key characteristics of carcinogens: relationship to the hallmarks of cancer, relevant biomarkers, and assays to measure them MT Smith, KZ Guyton, N Kleinstreuer, A Borrel, A Cardenas, WA Chiu, ... Cancer Epidemiology and Prevention Biomarkers 29 (10), 1887-1903, 2020 | 9 | 2020 |
| Exploiting microRNA and mRNA profiles generated in vitro from carcinogen-exposed primary mouse hepatocytes for predicting in vivo genotoxicity and … L Rieswijk, KJJ Brauers, MLJ Coonen, DGJ Jennen, SGJ van Breda, ... Mutagenesis 31 (5), 603-615, 2016 | 9 | 2016 |
| Tuberculosis infection and lung adenocarcinoma: Mendelian randomization and pathway analysis of genome-wide association study data from never-smoking Asian women JYY Wong, H Zhang, CA Hsiung, K Shiraishi, K Yu, K Matsuo, MP Wong, ... Genomics 112 (2), 1223-1232, 2020 | 8 | 2020 |
| A state-of-the-science review of arsenic’s effects on glucose homeostasis in experimental models F Castriota, L Rieswijk, S Dahlberg, MA La Merrill, C Steinmaus, MT Smith, ... Environmental health perspectives 128 (1), 016001, 2020 | 7 | 2020 |
| Human exposure to trichloroethylene is associated with increased variability of blood DNA methylation that is enriched in genes and pathways related to autoimmune disease and … RV Phillips, L Rieswijk, AE Hubbard, R Vermeulen, J Zhang, W Hu, L Li, ... Epigenetics 14 (11), 1112-1124, 2019 | 6 | 2019 |
| eNanoMapper–A database and ontology framework for design and safety assessment of nanomaterials G Kilic, B Fadeel, L Farcal, H Sarimveis, P Doganis, G Drakakis, G Tsiliki, ... Toxicology Letters, S118-S119, 2016 | 2 | 2016 |
| Answering Scientific Questions with linked European Nanosafety Data. EL Willighagen, M Rautenberg, D Gebele, L Rieswijk, F Ehrhart, J Chang, ... SWAT4LS, 2016 | 1 | 2016 |
| eNanoMapper updates and its collaborations with the community E Willighagen, F Ehrhart, L Rieswijk, N Jeliazkova, CTA Evelo, L Farcal, ... NanoSafety Cluster Newsletter 6, 14-17, 2015 | 1 | 2015 |
| InContext: curation of medical context for drug indications K Moodley, L Rieswijk, TI Oprea, M Dumontier Journal of Biomedical Semantics 12 (1), 1-15, 2021 | | 2021 |
| Using Gene Expression Data to Provide Evidence for the Key Characteristics of Human Carcinogens in Hazard Identification MS Linda Rieswijk 2018 Annual Meeting Abstract Supplement, Society of Toxicology, 2018 …, 2018 | | 2018 |
| Assessing the quality of manually curated drug indication and usage information via ontology term mappings MD Kody Moodley, Linda Rieswijk, Tudor Oprea Intelligent Systems for Molecular Biology: Bio-ontologies Community of …, 2017 | | 2017 |
